Smiling woman sitting in front of green wall at AlkermesSmiling woman sitting in front of green wall at AlkermesBlue Triangle graphic

News and Events

Sharing Stories of
Patients, Employees
and Communities

Featured News

September 22, 2021

Alkermes to Take Part in the Cantor Virtual Global Healthcare Conference

Read more

September 22, 2021

New Survey Provides Insights Into Drinking Behaviors During the Pandemic

Read more

September 13, 2021

Alkermes to Present Two Posters on Investigational Immuno-oncology Candidate, Nemvaleukin Alfa, at the 2021 European Society for Medical Oncology (E...

Read more

See all press releases

COVID-19 Response 

In response to the urgent and unexpected needs created by the COVID-19 pandemic, Alkermes acted quickly to prioritize the safety of our employees and our communities, and adapted our business practices to support uninterrupted supply of, and patient and provider access to, our marketed and investigational medicines.

Read our response   

Portrait of woman with mask in research laboratory environment

Alkermes at ASCO

We hosted a webcast in June 2021 with expert oncologists and ARTISTRY clinical program investigators to review data updates presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. 

Listen to the webcast

Lessons from Leadership

Senior Director and Research Oncology Program Lead Heather Losey, Ph.D. shares five leadership lessons she’s learned throughout her career as part of an Authority Magazine series highlighting inspirational women in STEM.

Read the article

Portrait of smiling Alkermes employee smiling

Blair Jackson in Alkermes office smiling.

Building for the Future

In a recent interview with Informa Connect's Xconomy, our Chief Operating Officer, Blair Jackson, discusses our ambitions and our evolving strategy in neuroscience and oncology. 

Read the article

Media Resources

Company Description

Alkermes is focused on developing innovative medicines that seek to address unmet needs of people living with serious mental illness, addiction and cancer. As a fully-integrated, global biopharmaceutical company, with U.S. locations in Massachusetts and Ohio, and locations in Dublin and Athlone, Ireland, we apply our scientific expertise and proprietary technologies to develop products designed to make a meaningful difference in the way people manage their diseases. Beyond our scientific pursuits, we also work to help support and enhance the systems through which these complex diseases are treated. We are committed to patient engagement, disease education and supporting policies that enable access to approved treatment options.

Media Inquiries

Email our media team

Company Logos


Company Photo


Corporate Fact Sheet


Follow us on our social channels   

blue triangle graphic

Statements and Positions

The idea that a corporation can play a profoundly positive role in society is central to our vision. It is our obligation to voice our beliefs about issues that impact the patients we serve, the communities in which we live and work and society at large.

Access to Medicines

Read our statement

Marketing Practices

Read our statement

Systemic Racism and Violence

Read our statement

Company Response to "Four Good Days"

Read our response